Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

Gut

Volumn 47, Issue 3, 2000, Pages 429-435

  Berasain, C ^a   Betes M ^a   Panizo, A ^a   Ruiz, J ^a   Herrero, J I ^a   Civeira, M P ^a   Prieto, J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cryptogenic hepatitis; Cryptogenic liver disease; Hepatitis B virus; Hepatitis C virus; Hepatitis G virus; Non alcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS DNA; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA;

ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; DNA, VIRAL; FEMALE; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0033857654     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.3.429     Document Type: Article

References (30)

1. 1 Paterlini P, Driss F, Nalpas B, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-9.
2. 2 Chung HT, Lai CL, Lok ASF. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995;22:25-9.
3. 3 Schmidt WX, Wu P, Cederna J, et al. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and HCV antibody test. J Infect Dis 1997;176:27-33.
4. 4 Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-6.
5. 5 Geller SA, Nichols WS, Rojter SE, et al. Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction. Hum Pathol 1996;27:1161-5.
6. 6 Kodali VP, Gordon SC, Silverman AL, et al. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994;89:1836-9.
7. 7 Romeo R, Pol S, Demeret C, et al. Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses. J Hepatol 1995;22:125-9.
8. 8 Huo TJ, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998; 28:231-6.
9. 9 Liang TJ, Baruch Y, Ben-Porath E, et al. Hepatitis B virus infection in patients with idiopatic liver disease. Hepatology 1991;13:1044-51.
10. 10 Zhang YY, Hansson BG, Kuo LS, et al. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HbsAg. Hepatology 1993;17:538-44.
11. 11 Fukuda R, Ishimura N, Kushiyama Y, et al. Hepatitis B virus X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis. Microbiol Immunol 1996;40:481-8.
12. 12 Uchida T, Shimojima M, Gotoh K, et al. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol 1994;38:281-45.
13. 13 International Working Party. Terminology of chronic hepatitis. Am J Gastroenterol 1995; 90:181-9.
14. 14 Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45.
15. 15 Bacon BR, Farahvash MJ, Janney CG, et al. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
16. 16 Ruiz J, Sangro B, Cuende JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
17. 17 Gil B, Qian C, Riezu-Boj JI, et al. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology 1993;18:1050-4.
18. 18 Volta U, De Franceschi L, Lari F, et al. Celiac disease hidden by cryptogenic hypertransaminasaemia. Lancet 1998; 352:26-9.
19. 19 Sarrazin C, Hermann G, Roth WK, et al. Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology. J Hepatol 1997;27:276-83.
20. 20 Mathiesen UL, Franzen LE, Fryden A, et al. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999;34:85-91.
21. 21 Goldstein NS, Kodali VP, Gordon SC. Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis. Am J Clin Pathol 1995;104:567-73.
22. 22 Greeve M, Ferrel L, Kim M, et al. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology 1993;17:593-8.
23. 23 Fong TL, Bisceglie AM, Gerber MA, et al. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993;18:1313-18.
24. 24 Loriot MA, Marcellin P, Walker F, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 1997;27: 251-8.
25. 25 Bahn A, Gerner P, Martiné U, et al. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. J Hepatol 1997;27:973-97
26. 26 Feitelson MA, Duan LX, Guo J, et al. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J Inject Dis 1995;172:713-22.
27. 27 Guilera M, Sáiz JC, López-Labrador FX, et al. Hepatitis G virus infection in chronic liver disease. Gut 1998;42:107-11.
28. 28 Hollingsworth RC, Minton EJ, Fraser-Moodie C, et al. Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK. Trent hepatitis C virus study group. J Viral Hepat 1998;5:165-9.
29. 29 Pessoa MG, Terrault NA, Detmer J, et al. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 1998;27:877-80.
30. 30 Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588-98.